A novel approach to the determination and characterization of HIV dementia

被引:6
作者
Brouwers, P
Mohr, E
Hildebrand, K
Hendricks, M
Claus, JJ
Baron, IS
Young, M
Pierce, P
机构
[1] NINCDS, BETHESDA, MD 20892 USA
[2] UNIV OTTAWA, FAC MED, OTTAWA, ON, CANADA
[3] GEORGETOWN UNIV, MED CTR, WASHINGTON, DC 20007 USA
关键词
D O I
10.1017/S0317167100038804
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Neuropsychological studies of the pattern and extent of cognitive impairment in HIV-infected patients have mostly used deviations from control values and/or cut-off scores as criteria for classification of dementia. There is, however, no agreement as to how to define impairment, and classification is imprecise. Method: The current study used a dementia classification matrix, developed with a step-wise linear discriminant analysis of neuropsychological data from patients with primary neurodegenerative dementias, to classify symptomatic HIV patients as demented or non-demented, and furher to differentiate cortical and subcortical dementia patterns. Thirty-two male and 2 female patients (mean age 39 +/- 2) with symptomatic HIV disease (mean absolute Cd4 count 195 +/- 41) participated in the study. Results: Thirty-fie per cent of patients were classified as demented. Of these, 83% showed a subcortical pattern and 17% a cortical profile of deficits. Significant differences between patients classified as subcortically demented and those categorized as normal on neuropsychological measures associated with subcortical integrity further validated the classification. Measures of psychiatric status between subgroups were similar. Conclusion: Since certain treatments may delay or reverse cognitive deficits, the use of an objective classification method based on discriminant analysis may help to identify patients who may benefit from therapy.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 60 条
[1]   STATEMENT CONCERNING THE NIMH NEUROPSYCHOLOGICAL BATTERY [J].
ADAMS, KM ;
HEATON, RK .
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1990, 12 (06) :960-962
[2]   REDUCED BASAL GANGLIA VOLUME IN HIV-1 ASSOCIATED DEMENTIA - RESULTS FROM QUANTITATIVE NEUROIMAGING [J].
AYLWARD, EH ;
HENDERER, JD ;
MCARTHUR, JC ;
BRETTSCHNEIDER, PD ;
HARRIS, GJ ;
BARTA, PE ;
PEARLSON, GD .
NEUROLOGY, 1993, 43 (10) :2099-2104
[3]   CLINICAL-PHARMACOLOGY OF 2',3'-DIDEOXYINOSINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN [J].
BALIS, FM ;
PIZZO, PA ;
BUTLER, KM ;
HAWKINS, ME ;
BROUWERS, P ;
HUSSON, RN ;
JACOBSEN, F ;
BLANEY, SM ;
GRESS, J ;
JAROSINSKI, P ;
POPLACK, DG .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) :99-104
[4]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[5]  
BORNSTEIN RA, 1993, AM J PSYCHIAT, V150, P922
[6]   COULD IT BE HIV .8. HIV-RELATED NEUROLOGICAL DISEASE [J].
BREW, BJ ;
CURRIE, JN .
MEDICAL JOURNAL OF AUSTRALIA, 1993, 158 (02) :104-108
[7]   INTERRELATIONS AMONG PATTERNS OF CHANGE IN NEUROCOGNITIVE, CT BRAIN IMAGING AND CD4 MEASURES ASSOCIATED WITH ANTIRETROVIRAL THERAPY IN CHILDREN WITH SYMPTOMATIC HIV-INFECTION [J].
BROUWERS, P ;
DECARLI, C ;
TUDORWILLIAMS, G ;
CIVITELLO, L ;
MOSS, H ;
PIZZO, P .
ADVANCES IN NEUROIMMUNOLOGY, 1994, 4 (03) :223-231
[8]   EFFECT OF CONTINUOUS-INFUSION ZIDOVUDINE THERAPY ON NEUROPSYCHOLOGICAL FUNCTIONING IN CHILDREN WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BROUWERS, P ;
MOSS, H ;
WOLTERS, P ;
EDDY, J ;
BALIS, F ;
POPLACK, DG ;
PIZZO, PA .
JOURNAL OF PEDIATRICS, 1990, 117 (06) :980-985
[9]   DIFFERENTIAL PERCEPTUAL-SPATIAL IMPAIRMENT IN HUNTINGTONS AND ALZHEIMERS DEMENTIAS [J].
BROUWERS, P ;
COX, C ;
MARTIN, A ;
CHASE, T ;
FEDIO, P .
ARCHIVES OF NEUROLOGY, 1984, 41 (10) :1073-1076
[10]  
BROUWERS P, 1989, J CLIN EXP NEUROPSYC, V11, P35